Developing a regulatory pathway for biosimilars and increasing market share of biosimilar products in British Columbia.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|
Provincial government policy on opioid prescribing and dispensing and proper role of generic manufacturers.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|